1h Free Analyst Time
The phage therapy market is forecasted to grow by USD 51 mn during 2023-2028, accelerating at a CAGR of 17.41% during the forecast period. The report on the phage therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by benefits of phage therapy over antibiotics, increasing application of phage therapy for animal health, and increasing application of phage therapy for human health.
The phage therapy market is segmented as below:
By Product
- Escherichia coli
- Staphylococcus aureus
- Salmonella
- Others
By Application
- Animal health
- Food industry
- Others
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
The report on the phage therapy market covers the following areas:
- Phage therapy market sizing
- Phage therapy market forecast
- Phage therapy market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global phage therapy market: Adaptive Phage Therapeutics, APS Biocontrol Ltd., Armata Pharmaceuticals Inc., Astellas Pharma Inc., BiomX Inc., CJ CheilJedang Corp., Cytophage Technologies Inc., Eliava Biopreparation LLC, Intralytix Inc., iNtRON Biotechnology Inc., JSC NPO Microgen, Locus Biosciences Inc., Micreos, Micromir, Nexabiome, Proteon Pharmaceuticals S.A., Taconic Biosciences Inc., TechnoPhage, ZeptoMetrix LLC, and Vitalis Wellness LLP.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing investments in phage therapy.'
According to the report, one of the major drivers for this market is the benefits of phage therapy over antibiotics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adaptive Phage Therapeutics
- APS Biocontrol Ltd.
- Armata Pharmaceuticals Inc.
- Astellas Pharma Inc.
- BiomX Inc.
- CJ CheilJedang Corp.
- Cytophage Technologies Inc.
- Eliava Biopreparation LLC
- Intralytix Inc.
- iNtRON Biotechnology Inc.
- JSC NPO Microgen
- Locus Biosciences Inc.
- Micreos
- Micromir
- Nexabiome
- Proteon Pharmaceuticals S.A.
- Taconic Biosciences Inc.
- TechnoPhage
- ZeptoMetrix LLC
- Vitalis Wellness LLP
